BioCrossroads Board of Directors members represent the state’s industry, academic and government sectors. The senior leaders on the Board are essential to BioCrossroads’ success, and they are united in their common commitment to find even more ways to collaborate, sustain investments and build upon the energy and assets Indiana already has.

D. Craig Brater, M.D. is the Chairman of the Board of Directors for BioCrossroads. A member of the organization’s Executive Committee and Board of Directors since the beginning of BioCrossroads, Dr. Brater is Dean of the Indiana University School of Medicine.

Leonard J. Betley	Chairman and President Chairman	Richard M. Fairbanks Foundation, Inc. and the Regenstrief Foundation Walther Cancer Foundation
Dr. Richard Buckius	Vice President for Research	Purdue University
Dr. Thomas Burish	Provost	University of Notre Dame
Wayne Burris	Senior Vice President and CFO	Roche Diagnostics Corporation
Darren Carroll	Vice President, Corporate Business Development	Eli Lilly and Company
Daniel Evans	President & CEO	Indiana University Health
Antonio Galindez	President & CEO	Dow AgroSciences
David Johnson	President & CEO	BioCrossroads
Dr. Jan Lundberg	Executive Vice President, Science and Technology and President of Lilly Research Laboratories	Eli Lilly and Company
Dr. Michael McRobbie	President	Indiana University
Dr. Samuel Nussbaum	Executive Vice President and Chief Medical Officer	WellPoint, Inc.
Daniel Peterson	Vice President Industry and Government Affairs	Cook Group, Inc.
William Ringo	Former Senior Vice President of Strategy and Business Development	Pfizer
Charles Schalliol	Counsel	Faegre Baker Daniels
Steve Schlegel	Vice President of Corporate Development	WellPoint
Jon Serbousek	President	Biomet Orthopedics
Deborah Keller	Corporate Senior Vice President and President, Central Laboratory Services	Covance
Sidney Taurel	Former Chairman of the Board	Eli Lilly and Company